Clicky

C4 Therapeutics, Inc.(CCCC) News

Date Title
Oct 9 C4 Therapeutics Announces Presentations and Participation in 7th Annual Targeted Protein Degradation & Induced Proximity Summit
Sep 3 C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors
May 22 We Think C4 Therapeutics (NASDAQ:CCCC) Can Afford To Drive Business Growth
May 10 C4 Therapeutics Inc (CCCC) Q1 2024 Earnings: Navigating Challenges with Strategic Collaborations
May 8 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Apr 29 C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr 9 C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
Apr 8 C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
Mar 28 Here’s Why Meridian Small Cap Growth Fund Trimmed C4 Therapeutics (CCCC)
Mar 5 C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024
Mar 4 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
Jan 11 C4 (CCCC) Up 6% on Restructuring Plan to Curb Cash Burn
Jan 9 C4 Therapeutics, Inc. (CCCC)'s Technical Outlook is Bright After Key Golden Cross
Jan 9 C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
Jan 5 Axsome (AXSM) Surges 7.8%: Is This an Indication of Further Gains?
Jan 4 C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
Jan 4 C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Jan 1 Wall Street Analysts See a 197.7% Upside in C4 Therapeutics, Inc. (CCCC): Can the Stock Really Move This High?
Dec 29 Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?
Dec 28 The Zacks Analyst Blog Highlights Allogene Therapeutics, Arcutis Biotherapeutics and C4 Therapeutics